首页> 外国专利> METHOD FOR ACQUIRING DATA FOR DISTINGUISHING PRESENCE OF CANCER CELLS AND/OR DISTINGUISHING ANTICANCER DRUG RESISTANCE, METHOD FOR ACQUIRING PREDICTION DATA, USE OF DISTINCTION MARKER IN SAME, AND DISTINGUISHING KIT

METHOD FOR ACQUIRING DATA FOR DISTINGUISHING PRESENCE OF CANCER CELLS AND/OR DISTINGUISHING ANTICANCER DRUG RESISTANCE, METHOD FOR ACQUIRING PREDICTION DATA, USE OF DISTINCTION MARKER IN SAME, AND DISTINGUISHING KIT

机译:获取数据以区分癌细胞和/或区分抗癌耐药性,用于获取预测数据的方法的方法,同样使用区分标记和区分试剂盒

摘要

The present invention addresses the problem of providing a method for acquiring data for distinguishing the presence of cancer cells and/or distinguishing anticancer drug resistance, a method for acquiring prediction data, a use of a distinction marker in said method, and a distinguishing kit, and in particular addresses the problem of distinguishing anticancer drug resistance before an anticancer drug is administered to a patient. Polysulfides, which are markers for anticancer drug resistance, are distinguished in cancerous tissue of a cancer patient prior to administration of an anticancer drug, thereby making it possible to distinguish anticancer drug resistance to the cancerous tissue of the cancer patient.
机译:本发明解决了提供用于获取用于区分癌细胞和/或区分抗癌药物阻力的数据的方法的问题,用于获取预测数据的方法,在所述方法中使用区分标记和区分套件,特别地解决了在给予患者的抗癌药物之前区分抗癌耐药性的问题。在施用抗癌药物之前,抗癌耐药性标记的多硫化物在癌症患者的癌组织中区分,从而可以将抗癌药物抵抗与癌症患者的癌组织区分开来。

著录项

  • 公开/公告号WO2021045202A1

    专利类型

  • 公开/公告日2021-03-11

    原文格式PDF

  • 申请/专利权人 KEIO UNIVERSITY;

    申请/专利号WO2020JP33640

  • 发明设计人 HISHIKI TAKAKO;SUEMATSU MAKOTO;

    申请日2020-09-04

  • 分类号A61P35;G01N21/65;C12N5/09;C12Q1/02;A61K33/243;G01N33/50;A61K31/7068;

  • 国家 JP

  • 入库时间 2022-08-24 17:41:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号